US Prescription Medications Are Expensive
High prescription drug costs in the U.S. can lead to skipped doses, subsequent poor health outcomes, and financial hardship.
The U.S. spends more on prescription drugs than any other country. Global spending on prescription drugs in 2020 was ~$1.3 trillion; the United States alone spent ~$350 billion.
In 2022, U.S. prices for brand drugs were at least 3.22 times as high as prices in comparison to OECD countries.
Up to 30% of Americans cite cost as their reason for skipping prescription doses compared to under 4% in the UK and Germany.
Skipping medicines can result in poorer health, reduced productivity, and higher hospitalizations.
In Washington State, researchers found cancer patients were 2.5 times more likely to declare bankruptcy than those without the disease.
Why Is It This Way?
One of the primary reasons why U.S. drug prices are higher than other countries are the lack of a central body negotiating drug prices for consumers. Therefore, the market is skewed by monopolies and drug company lobbies. Drug companies justify high prices due to the costs of developing new medicines. However, a recently published article by the JAMA open network found no association between high drug prices and the cost of R&D.
How Can We Solve This
Procurement
Through decades-long partnerships with industry leaders, we can leverage our relationships and volume to procure original brands at very competitive prices.
Supply Chain
We leverage on our volume and networks to obtain original brand drugs.
Clinician Led
Physician and pharmacist-led clinician teams ensure we put patient safety first.
International Partners
With locations in Australia, Canada, and New Zealand. We can diversify risk.
Mission Driven
Our aim is to lower costs for our clients without compromising on delivery and quality.
